Seelos Therapeutics Inc (SEEL)

[saorsa]

LB, I emailed their investor relations ([e-mail]) and asked when they were launching Vitaros. I received the info below.

"This product will be launched on a country by country basis as approvals are obtained. The first launch is planned to take place in Spain at the end of 2014."

When I followed up and asked why they were delaying when Takeda had already launched, they got a bit snotty with me and sent this:

"We are not delaying the launch. The approval is in Apricus’s name and it has to be transferred to Recordati.
We will obviously launch in each market where we have rights as soon as all the necessary regulatory procedures are completed satisfactorily."